What is Penumbra Inc Annual Revenue?

Penumbra Inc Annual Revenue rose 12.86%, in the last year to $1,194.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

What is Penumbra Inc Annual Net Profit?

Penumbra Inc Annual Net Profit fell 84.59% in the last year to $14.01 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

What is Penumbra Inc Price to Earning Ratio?

Penumbra Inc Price to Earning Ratio is 765.69, higher than its sector PE ratio of 29.09.

What is Penumbra Inc Stock Price?

Penumbra Inc Stock Price rose 36.81% and outperformed its sector by 31.38% in the past year.

What is Penumbra Inc Quarterly Revenue?

Penumbra Inc Quarterly Revenue rose 10.83% YoY to $315.52 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

What is Penumbra Inc Quarterly Net profit?

Penumbra Inc Quarterly Net profit fell 37.87% YoY to $33.68 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

What is Penumbra Inc Debt to Equity Ratio?

Penumbra Inc Debt to Equity Ratio of 0.19 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Penumbra Inc Return on Equity(ROE)?

Penumbra Inc Return on Equity(ROE) for the last financial year was 1.2%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Penumbra Inc Mutual Fund Holding?

Penumbra Inc Mutual Fund Holding decreased by 1.52% in the last quarter to 83.79.

What is Penumbra Inc Promoter Share Holding?

Penumbra Inc Promoter Share Holding increased by 0.11% in the most recent quarter to 1.45%.

What is Penumbra Inc Interest Coverage Ratio?

Penumbra Inc Interest Coverage Ratio is 15.72, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Penumbra Inc Institutional Holding?

Penumbra Inc Institutional Holding increased by 0.31% in the last quarter to 91.02.

How is the Penumbra Inc today?

The Penumbra Inc today is trading in the down by -0.16% at 277.35.

How has Penumbra Inc performed historically?

The Penumbra Inc is currently trading down -0.16% on an intraday basis in the past week the index rose 1.85%. The index has been up 5.18% in the past quarter and rose 36.81% in the past year. You can view this in the overview section.

Penumbra Inc XNYS: PEN

Penumbra Inc Live Share Price Today, Share Analysis and Chart

Name: Penumbra Inc: Is Infosys Ltd. worth buying?
Item: Penumbra Inc
Rating: 2.068958375
Author: Trendlyne DVM scores

Expensive Performer

Download real time

277.35 -0.44 (-0.16%)

87.40% Gain from 52W Low

326.8K XNYS Volume

XNYS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Penumbra Inc is on 23 Apr 2025 for the purpose of Penumbra Inc First Quarter Earnings Results for 2025 See details

Penumbra Inc Key Metrics

My Metrics

Select

Market Capitalization High in industry Unavailable in chosen country	10,728.9
PE TTM High in industry Unavailable in chosen country	765.7
PEG TTM Negative PEG TTM Unavailable in chosen country	-9.1
Price to Book High in industry Unavailable in chosen country	9.3
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	91
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	10.8
Operating Revenue growth TTM % Below industry Median Unavailable in chosen country	12.9
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-37.9
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-84.6
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	13.6
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	7.2
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	12.4
ROE Annual % Below industry Median Unavailable in chosen country	1.2
RoA Annual % Below industry Median Unavailable in chosen country	0.9

All financials are in USD Million and price data in USD

Medium Financial Strength

50.0 / 100

Expensive Valuation

6.2 / 100

Technically Neutral

59.4 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

309

1Yr Price target upside is 11%

17 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Sell Zone

76.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Penumbra Inc Stock Price Analysis

Day Price Range -0.2% 1 Day return Unavailable in chosen country	277.4 (LTP) 273280.8 LowHigh
Week Price Range 1.8% 1 Week return Unavailable in chosen country	277.4 (LTP) 266.8280.8 LowHigh
Month Price Range -0.8% 1 Month return Unavailable in chosen country	277.4 (LTP) 246.4288.6 LowHigh
52 Week Price Range 36.8% 1 Year return Unavailable in chosen country	277.4 (LTP) 148310 LowHigh

View full Share Price History

Penumbra Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Penumbra Inc's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

0.4

Avg. Estimate

3.6

Low Estimate

3.4

High Estimate

3.9

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 908.3% in FY25

Consensus Recommendation

19 ANALYST Recommendations

BUY

The consensus recommendation from 19 analysts for Penumbra Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Penumbra Inc Stock Analysis

Penumbra Inc stock analysis with key metrics, changes, and trends.

Penumbra Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$1,194.62 M	12.86%	positive	Annual Revenue rose 12.86%, in the last year to $1,194.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.
Annual Net Profit	$14.01 M	84.59%	negative	Annual Net Profit fell 84.59% in the last year to $14.01 M. Its sector's average net profit growth for the last fiscal year was 4.36%.
Price to Earning Ratio	765.69	-	negative	Price to Earning Ratio is 765.69, higher than its sector PE ratio of 29.09.
Stock Price	$277.35	36.81%	positive	Stock Price rose 36.81% and outperformed its sector by 31.38% in the past year.
Quarterly Revenue	$315.52 M	10.83%	positive	Quarterly Revenue rose 10.83% YoY to $315.52 M. Its sector's average revenue growth YoY for the quarter was 8.5%.
Quarterly Net profit	$33.68 M	37.87%	negative	Quarterly Net profit fell 37.87% YoY to $33.68 M. Its sector's average net profit growth YoY for the quarter was 32.89%.
Debt to Equity Ratio	0.19	-	positive	Debt to Equity Ratio of 0.19 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	1.20 %	1.2%	negative	Return on Equity(ROE) for the last financial year was 1.2%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.
Mutual Fund Holding	83.79 %	-1.52%	negative	Mutual Fund Holding decreased by 1.52% in the last quarter to 83.79.
Promoter Share Holding	1.45 %	0.11%	positive	Promoter Share Holding increased by 0.11% in the most recent quarter to 1.45%.
Interest Coverage Ratio	15.72	-	positive	Interest Coverage Ratio is 15.72, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	91.02 %	0.31%	positive	Institutional Holding increased by 0.31% in the last quarter to 91.02.

VIEW LESS

Loading data..

Penumbra Inc - Company Profile

What does Penumbra Inc do?

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

Penumbra Inc Management structure

All Gross Remunerations are in USD

Ms. Johanna Roberts

Executive Vice President, General Counsel and Secretary

2.19 M

2024

Gross Remuneration

Year

Ms. Maggie Yuen

Chief Financial Officer

1.78 M

2024

Gross Remuneration

Year

Mr. Lambert Shiu

Chief Accounting Officer

1.56 M

2024

Gross Remuneration

Year

Mr. Adam Elsesser

Chief Executive Officer, President and Chairman of the Board

630.47 K

2024

Gross Remuneration

Year

Penumbra Inc Board of directors

All Gross Remunerations are in USD

Mr. Don Kassing

Presiding Independent Director

2025

Gross Remuneration

Year

Penumbra Inc Live Share Price Today, Share Analysis and Chart

87.40% Gain from 52W Low

Penumbra Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Penumbra Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Penumbra Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Penumbra Inc's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 908.3% in FY25

Consensus Recommendation

The consensus recommendation from 19 analysts for Penumbra Inc is BUY

Penumbra Inc Stock Analysis

Penumbra Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 12.86%, in the last year to $1,194.62 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit fell 84.59% in the last year to $14.01 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio is 765.69, higher than its sector PE ratio of 29.09.

Stock Price rose 36.81% and outperformed its sector by 31.38% in the past year.

Quarterly Revenue rose 10.83% YoY to $315.52 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit fell 37.87% YoY to $33.68 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio of 0.19 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 1.2%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding decreased by 1.52% in the last quarter to 83.79.

Promoter Share Holding increased by 0.11% in the most recent quarter to 1.45%.

Interest Coverage Ratio is 15.72, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.31% in the last quarter to 91.02.

Penumbra Inc - Company Profile

What does Penumbra Inc do?

Penumbra Inc Management structure

Ms. Johanna Roberts

Executive Vice President, General Counsel and Secretary

Ms. Maggie Yuen

Chief Financial Officer

Mr. Lambert Shiu

Chief Accounting Officer

Mr. Adam Elsesser

Chief Executive Officer, President and Chairman of the Board

Penumbra Inc Board of directors

Mr. Don Kassing

Presiding Independent Director

Penumbra Inc FAQ

How is Penumbra Inc today?

Penumbra Inc today is trading in the red, and is down by -0.16% at 277.35.